DisseminatedIntravascularCoagulaionPPT课件_第1页
DisseminatedIntravascularCoagulaionPPT课件_第2页
DisseminatedIntravascularCoagulaionPPT课件_第3页
DisseminatedIntravascularCoagulaionPPT课件_第4页
DisseminatedIntravascularCoagulaionPPT课件_第5页
已阅读5页,还剩39页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、1 disseminated intravascular coagulation(dic) dengli hong md phdgroup head of medical stem cell biologyshanghai jiao-tong university school of medicinekey lab of cell differentiation and apoptosis of chinese ministry of education tel:mail: http:/ 研究员研究员 医学干细胞研究组组长医学干细胞研究组组长 贡献:贡献:致力于研究

2、干细胞疾病中干细胞在生理和病理性niche中的功能和基因组稳定性及克隆性演化。成果发表在science、 cell stem cell和 jci等杂志。 最重要的贡献是,第一次鉴定了前白血病干细胞(hong d, et al. science 2008),被认为是肿瘤研究的重大突破,延伸研究提出了肿瘤干细胞的克隆性演化模型。 教育经历:教育经历: 1992,武汉同济医科大学临床医学本科。 1998,武汉同济医科大学血液内科研究生。 2009,牛津大学分子医学研究所哲学博士。工作简历工作简历: 1998-2000武汉同济医科大学附属同济医院血液内科医师。2000-2003意大利都灵大学ircc肿

3、瘤研究所博士后。2003-2006英国牛津大学wimm分子医学研究所助理研究员。2006-2009英国牛津大学wimm分子医学研究所研究员。2009-今上海交大医学科学研究院/细胞分化与凋亡教育部重点实验室研究员, 医学干细胞组组长。医学干细胞研究组医学干细胞研究组欢迎你!欢迎你! 研究方向:研究方向:1. 1.干细胞干细胞在肿瘤起始和发展过程中的在肿瘤起始和发展过程中的克隆性演化克隆性演化和和表观遗传调控。表观遗传调控。2. 2.造血造血干细胞干细胞在生理和病理性在生理和病理性niche中的功能和基因组稳定性。中的功能和基因组稳定性。3. 3. 重编程干细胞重编程干细胞在医学上的应用。在医学

4、上的应用。正在承担的研究项目:正在承担的研究项目:1.国家自然基金重大研究计划培育项目:tel-aml1启动的干细胞克隆性演化的表观遗传调控机制。(2010-2012) 2国家自然科学基金重大国际合作研究项目:bcr-abl 相关急性淋巴细胞白血病干细胞的克隆性演化的遗传变异多样性。(2012-2016)3973子项目:肿瘤干细胞的动态演进及干预研究。(2012-2016)掌握掌握和和熟悉熟悉内容内容 1. definition of dic 2. causes of dic 3. pathogenesis of dic 4. predisposing factors to dic5. mai

5、n clinical features of dic6. types and stages of dic7. treatment of dicdefinition disseminated intravascular coagulation (dic) is a complex systemic thrombohemorrhagic disorder involving the generation of intravascular fibrin, the consumption of procoagulants and platelets, and secondary activation

6、of fibrinolysis. the resultant clinical condition is characterized by intravascular coagulation and hemorrhagecoagulation hypercoagulable state thrombusfibrinolysis hypocoagulable state hemorrhage掌握掌握和和熟悉熟悉内容内容 1. definition of dic 2. causes of dic 3. pathogenesis of dic 4. predisposing factors to d

7、ic5. main clinical features of dic6. types and stages of dic7. treatment of dicdiseases associated with dic nsepsis/severe infection 30% nmalignancy 25% solid and myeloproliferative malignancies nobstetric complications 20% amniotic fluid embolism, abruptio placentae retained dead fetus syndrome ntr

8、auma (neurotrauma) ,organ destruction, burns 15%nsevere hepatic failurenrheumatologic illness adult stills disease, lupus nvascular abnormalities kasabach-merritt syndrome, large vascular aneurysmsnhemolysistriggering factors 掌握掌握和和熟悉熟悉内容内容 1. definition of dic 2. causes of dic 3. pathogenesis of di

9、c 4. predisposing factors to dic5. main clinical features of dic6. types and stages of dic7. treatment of dic balance between coagulation and anti-coagulation anti-coagulationfibrinolysiscoagulation 抗凝抗凝凝血凝血纤溶纤溶 coagulation cascade xxaxfribrinfibrinogenfmviiiviiiaca2+vii/viia-tf-ca2+xiixiiapkkkcolla

10、genhkxixiaviiiaca2+ixaixintrinsic pathway vaca2+thrombin iiextrinsic pathway coagulation cascade xxaxfribrinfibrinogenfmviiiviiiaca2+vii/viia-tf-ca2+xiixiiapkkkcollagenhkxixiaviiiaca2+ixaixintrinsic pathway vaca2+thrombin iiextrinsic pathway anti-coagulation n cellular system: monocyte/ macrophagen

11、anticoagulants in plasma1. at,tfpi,heparin co-factor ii 可灭活可灭活a,a,a,a,a等等; 凝血酶与血管内皮细胞表面肝素样物质结合,继而被凝血酶与血管内皮细胞表面肝素样物质结合,继而被at- 灭活灭活2. protein c systemprotein c system 蛋白蛋白c c激活的蛋白激活的蛋白c c(apcapc)灭活灭活aa,aa蛋白蛋白s s内皮细胞内皮细胞血栓调节蛋白血栓调节蛋白tmtm凝血酶凝血酶 fibrinolytic system plasminogenplasmin 纤溶酶纤溶酶coagulation &am

12、p; anticoagulation imbalance n haemorrhage or thrombosis will appear when the balance between coagulation and anticoagulation is disturbed.n inappropriate clotting of blood can obstruct vital organ circulation. n systemic activation of coagulation in its most extreme form is known as disseminated in

13、travascular coagulation (dic).凝血系统激活凝血系统激活凝血凝血抗凝抗凝正常凝血正常凝血- -抗凝平衡抗凝平衡凝血亢进,抗凝纤溶减弱凝血亢进,抗凝纤溶减弱凝血低下,抗凝或纤溶增强凝血低下,抗凝或纤溶增强 继发性纤溶亢进继发性纤溶亢进(凝血因子破坏,(凝血因子破坏,fdp生成)生成)广泛广泛微血栓微血栓形成形成止、凝血功能障碍,出血倾向止、凝血功能障碍,出血倾向凝血因子消耗,血小板减少凝血因子消耗,血小板减少dic时凝血与抗凝血平衡紊乱的演变过程时凝血与抗凝血平衡紊乱的演变过程 mechnism1: 组织因子释放,启动外源性凝血系统组织因子释放,启动外源性凝血系统xx

14、axfribrinfibrinogenfmviiiviiiaca2+vii/viia-tf-ca2+viiiaca2+ixaixvaca2+thrombin iiextrinsic pathway 创伤,烧伤,大手术,产科意外创伤,烧伤,大手术,产科意外肿瘤组织坏死,白血病细胞破坏。肿瘤组织坏死,白血病细胞破坏。 mechnism2: 血管内皮细胞损伤血管内皮细胞损伤 mechnism3: 血细胞的大量破坏,血小板被激活血细胞的大量破坏,血小板被激活1. rbc破坏,释放大量破坏,释放大量adp,促进血小板粘附,聚集。,促进血小板粘附,聚集。2. wbc破坏释放破坏释放tf样物质,样物质,wb

15、c受刺激表达受刺激表达tf。3. plt激活、粘附、聚集,促进凝血。激活、粘附、聚集,促进凝血。 mechnism4: 促凝物质释放入血促凝物质释放入血严重感染引起严重感染引起dic的发病机制的发病机制1234掌握掌握和和熟悉熟悉内容内容 1. definition of dic 2. causes of dic 3. pathogenesis of dic 4. predisposing factors to dic5. main clinical features of dic6. types and stages of dic7. treatment of dicimpairment o

16、f reticuloendothelial system n res is a cleaner: 1. products of intravascular coagulation (free fibrin, prothrombinase, pf3).2. various initiators of the process (endotoxin, tissue fragments, antigen-antibody complexes, thromboplastins, red cell stroma). 3. the hepatic cells are of primary importanc

17、e in the clearance of activated coagulation factors (ixa, xa and xiia). n the cleaner is too busy in dic, various substances saturate or block the clearance function of reticuloendothelial system. (shwartzman reaction in animals).n reticuloendothelial system is suppressd by glucocorticoid or in the

18、patients with liver diseaseshepatic dysfunction hemostasis is intimately related to liver function, because most coagulation factors are synthesized by liver parenchymal cells and the livers reticuloendothelial system serves an important role in the clearance of activation products. the extent of co

19、agulation abnormalities depends upon the degree of disturbed liver function. n acute or chronic hepatocellular diseases may display decreases in the vitamin k-dependent factors (prothrombin; factors vii, ix, and x; proteins c and s), whereas other parameters remain normal. n patients with hepatic fa

20、ilure may present with the entire spectrum of factor deficiencies and may even develop dic. n patients with liver cirrhosis have a wide spectrum of abnormalities. except for factor viii:c and von willebrand factor, all procoagulant and inhibitory factors are decreased, which is a reflection of impai

21、red protein synthesis. abnormal fibrinogen and prothrombin molecules can be identified. platelets are quantitatively and qualitatively altered, and most patients develop dic.hypercoagulable state hypercoagulable state: the platelet and several kinds of clotting factors (factor i, ii, vii, viii, ix a

22、nd x, etc.) in blood are increased, while the substances with the action of anticoagulation and with the activity of fibrinolysis are deceased. for instance, 1. the blood in pregnancy after 4 months bigins to increase coagulability, which is most marked in the terminal stage of pregnancy. therefore

23、the incidence of dic is elevated in obstetrical accidents. 2. acidosis, common in some patients, promotes the activation of clotting cascade by reducing the ph of the blood.disorder of microcirculation n shock usually accompanies disorder of microcirculation permitting activated clotting factors to

24、accumulated in one region making it easier to develop into a state of dic: 1. stasis of blood flow, 2. aggregation of blood cells 3. appearance of sludging, n the stasis of blood in giant hemangioma may somehow contribute to the development of dic.inhibition of fibrinolysis n aging, smoking, diabete

25、s.n using antifibrinolytic agents. 掌握掌握和和熟悉熟悉内容内容 1. definition of dic 2. causes of dic 3. pathogenesis of dic 4. predisposing factors to dic5. main clinical features of dic6. types and stages of dic7. treatment of dicbleeding n include:1. petechiae and purpura (found in most patients), hemorrhagic

26、bullae, wound bleeding; 2. especially oozing from a surgical or traumatic wound is common in patients who have undergone surgery or suffered trauma. 3. oozing from venipuncture sites or intraarterial lines is another common finding. 4. large subcutaneous hematomas and deep tissue bleeding are also o

27、ften seen.1. bleeding causes: clotting factors consumption fdp generation activation of fibrinolytic system vessel damageof consumption, secondary.shock nexcess bleedingnthrombus formation results in a diminished return of venous blood to the heartnactivation of the kinin(激肽)system leads to increase

28、d vascular permeability, hypotension, and shockncreation of fdp result in enhanced vasodilationnmyocardial infarctionend-organ damage / failure nimpaired blood flow caused by microvascular thrombosisnischemia reperfusion injurynsystemic inflammatory response syndrom nmultiple organ dysfunction syndr

29、omepathogenesislkidneys renal damage seen in 25% of dic cases in one serieslliver hepatic dysfunction in 19%llungs respiratory dysfunction in 16%microangiopathic hemolytic anemia 裂体细胞掌握掌握和和熟悉熟悉内容内容 1. definition of dic 2. causes of dic 3. pathogenesis of dic 4. predisposing factors to dic5. main cli

30、nical features of dic6. types and stages of dic7. treatment of dic促凝物质促凝物质纤溶活性纤溶活性血液凝固性血液凝固性分期分期高凝期高凝期消耗性低凝期消耗性低凝期 继发性纤溶亢进期继发性纤溶亢进期lab凝血时间、pt血小板粘附性血小板数纤维蛋白原血栓(+)出、凝血时间pt血小板凝血因子纤溶活性/n纤溶活性(优球蛋白溶解时间)纤溶酶原3p 试验(+)stages plasma protamine paracoagulation d-dimer formationtypes n acute decompensated dicn ch

31、ronic compensated diccompensated dic: when the stimulus for coagulation is mild, the liver can increase production of clotting factors to up to 5 times the normal rate, in an effort to maintain plasma levels. similarly, platelet production can increase up to 10 times. thus, although coagulation and fibrinolysis are in progress, platelet counts and fibrinogen levels may be normal or only marpinally reduced. these patients rarely bleed spontaneously or from

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论